PharmaDS 2026
Conference Focus
Data science across pharma, AI applications, statistical methodologies
Overview
PharmaDS 2026 is a premier conference dedicated to the intersection of data science, artificial intelligence, and statistical methodologies within the pharmaceutical and biotechnology sectors. Organized by the New England Statistical Society (NESS), the event serves as a vital forum for professionals to explore advanced computational techniques, machine learning applications in drug discovery, and rigorous statistical frameworks for clinical trials. It is highly regarded for bridging the gap between theoretical data science research and practical, regulatory-compliant implementation in the life sciences industry. The conference distinguishes itself by focusing on the technical challenges of data integration, real-world evidence, and the ethical deployment of AI in healthcare. By bringing together academic researchers, industry practitioners, and regulatory experts, PharmaDS fosters a collaborative environment that addresses the evolving landscape of data-driven decision-making in drug development, from early-stage research to post-market surveillance.
Why Attend
Professionals should attend PharmaDS 2026 to gain actionable insights into cutting-edge AI and statistical applications that are reshaping drug development. The hybrid format offers excellent networking opportunities with industry leaders and academic experts. Attendees will learn how to navigate the complexities of data-driven regulatory submissions, optimize clinical trial designs, and leverage emerging technologies to accelerate time-to-market while maintaining high standards of data integrity.
Key Topics & Sessions
- •AI and Machine Learning in Drug Discovery
- •Advanced Statistical Methodologies for Clinical Trials
- •Real-World Evidence (RWE) and Data Integration
- •Regulatory Perspectives on AI/ML in Pharma
- •Digital Biomarkers and Wearable Data
- •Causal Inference in Observational Studies
- •Data Governance and Ethical AI
- •Precision Medicine and Predictive Modeling
- •Automated Data Pipeline Optimization
- •Bayesian Methods in Drug Development
Who Should Attend
Conference History
PharmaDS is organized by the New England Statistical Society (NESS), a professional organization founded to promote the advancement of statistics and data science. The conference series has grown to become a key technical event, reflecting the increasing importance of data science in modern pharmaceutical research and development.
Venue & Location
The venue for 2026 is TBD. The conference utilizes a hybrid format, combining in-person sessions with virtual access via a dedicated online platform to facilitate global participation.
Related Conference Categories
This conference covers topics in the following pharma and life sciences domains. Explore more events in each category using our conference directory filters.
Resources & Links
About the PharmaDS 2026 Conference
PharmaDS 2026 is a hybrid event scheduled for 2026-03-23 to 2026-03-25 in TBD. The conference focuses on data science across pharma, ai applications, statistical methodologies. This event is categorized under AI & Machine Learning in Pharma in our conference directory.
PharmaDS 2026 is a premier conference dedicated to the intersection of data science, artificial intelligence, and statistical methodologies within the pharmaceutical and biotechnology sectors. Organized by the New England Statistical Society (NESS), the event serves as a vital forum for professionals to explore advanced computational techniques, machine learning applications in drug discovery, and rigorous statistical frameworks for clinical trials. It is highly regarded for bridging the gap between theoretical data science research and practical, regulatory-compliant implementation in the life sciences industry. The conference distinguishes itself by focusing on the technical challenges of data integration, real-world evidence, and the ethical deployment of AI in healthcare. By bringing together academic researchers, industry practitioners, and regulatory experts, PharmaDS fosters a collaborative environment that addresses the evolving landscape of data-driven decision-making in drug development, from early-stage research to post-market surveillance.
Professionals attending conferences like PharmaDS 2026 gain access to cutting-edge insights, peer networking, and exposure to the latest technologies shaping the pharmaceutical and biotechnology sectors. Whether you are evaluating new vendors, seeking regulatory updates, or expanding your professional network, industry conferences remain one of the most effective ways to stay current in life sciences.
AI and machine learning continue to transform the pharmaceutical industry, from drug discovery to commercial operations. Conferences featuring AI content provide valuable exposure to real-world implementations and emerging capabilities. Explore our Pharmaceutical GenAI Tracker for a comprehensive view of AI deployments across the industry.
Looking for guidance on which conferences to attend or how to build your event strategy for 2026? Book a meeting with the IntuitionLabs team to discuss your priorities and how we can support your team.